−10.63 MUSD
2.23 MUSD
2.91 M
About Ensysce Biosciences Inc.
Sector
Industry
CEO
D. Lynn Kirkpatrick
Website
Headquarters
La Jolla
Founded
2003
ISIN
US2936021169
FIGI
BBG00JM7K381
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
